Skip to content

The (cost) effectiveness of an online intervention (MamaKits) for pregnant women with affective symptoms: a randomised controlled trial

The (cost) effectiveness of an online intervention (MamaKits) for pregnant women with affective symptoms: a randomised controlled trial - Mamakits-online study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39770
Enrollment
286
Registered
2013-11-27
Start date
2014-03-19
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angststoornissen en -afwijkingen NEG Depression postpartum

Interventions

*MamaKits online* is based on an internet version of PST, which is proven effective for reducing anxiety and depressive symptoms in the general adult population [22]. The core assumption of PST is t

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: participants are included if: 1 they are pregnant in any stage of their pregnancy until 10 weeks before the expected date of delivery 2 they are 18 years or older and 3 they return an informed consent and 4 they have symptoms of depression and/or anxiety as defined by scoring above the cut-off of 15 ( *16) on the in the Center for Epidemiological Studies Depression scale (CES-D) and/or above the cut-off of 7 ( * 8) on the Hospital Anxiety and Depressionscale (HADS) and 5 they have access to a computer and 6 they have sufficient knowledge of the Dutch language

Exclusion criteria

Exclusion criteria: Exclusion criteria are: 1.age under 18 2.expected delivery date within 10 weeks. These women will be offered the intervention 6 weeks after giving birth at the same time as the controlgroup. 3.Symptoms are to mild as defined by a CES-D

Design outcomes

Primary

MeasureTime frame
Decrease in depressive and anxiety symptoms shortly after the intervention and 6 weeks postpartum, as measured with the CES-D and the HADS-A

Secondary

MeasureTime frame
Improved perinatal outcome, as decreased pre-term birth and growth restriction) Less costs in medical consumption and in the social field

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)